bioRxivMicrobiologyPreprint
A global map of the Zika virus phosphoproteome reveals host-driven regulation of viral budding and cytopathogenicity
I. Manuelyan, A. M. Schmoker, B. L. Yount, P. Eisenhauer, J. I. Keller, C. Gold, D. Terino, C. M. Ziegler, J. Alexander, H. E. Driscoll, E. Hutchinson, D. Bhella, C. D. Syme, D. G. Widman, M. T. Heise, R. S. Baric, B. A. Ballif, J. W. Botten
Abstract
Flaviviruses are enveloped, positive-strand RNA viruses that cause millions of infections in the human population annually. Although Zika virus (ZIKV) had been detected in humans as early as the 1950s, its reemergence in South America in 2015 resulted in a global health crisis. While flaviviruses encode 10 proteins that can be post-translationally modified by host enzymes, little is known regarding post-translational modifications (PTMs) of the flavivirus proteome. We used mass spectrometry to comprehensively identify host-driven PTMs on the ZIKV proteome. This approach allowed us to identify 43 PTMs across 8 ZIKV proteins, including several that are highly conserved within the Flavivirus genus. Notably, we found two phosphosites on the ZIKV envelope protein that are functionally important for viral propagation. Both appear to regulate viral budding, while one also impacts ZIKV cytopathogenicity. Additionally, we discovered host kinases that interact with ZIKV proteins and determined that Bosutinib--an FDA-approved tyrosine kinase inhibitor that targets some of these host kinases--impairs ZIKV growth, in part by blocking phosphorylation of a tyrosine residue on the envelope protein. Thus, we have defined a high-resolution map of host-driven PTMs on ZIKV proteins as well as cellular interacting kinases, uncovered novel mechanisms of host driven-regulation of ZIKV budding and cytopathogenicity, and identified an FDA-approved inhibitor of ZIKV growth.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PTBP1 is upregulated by Zika virus infection via HIF-1alpha signal and hijacks NS1 protein to induce NS1 degradation to restrain viral replication
Menglan Rao, Yue Kong, … Zhen Luo·Journal of VirologyPeer-reviewed·Apr 27, 2026
- Zika and Dengue Viruses Differentially Modulate Host mRNA Processing Factors Defining Its Virulence
Aaron Scholl, Binsheng Gong, … Sandip De·NAR Molecular MedicinePeer-reviewed·Mar 29, 2025
- Discovery of genes that modulate flavivirus replication in an interferon-dependent manner
S. Lesage, M. Chazal, … n. jouvenet·bioRxiv·Jul 20, 2021
- Antiviral activity of rosemary extract against Zika virus in human dermal fibroblasts
Jordan T. Masi, Robert W. E. Crozier, … Adam J. MacNeil·bioRxiv·Jan 30, 2025
- The clinically approved antiviral drug sofosbuvir impairs Brazilian zika virus replication
Caroline Q. Sacramento, Gabrielle R. de Melo, … Thiago Souza·bioRxiv·Jul 6, 2016
- The Hao-Fountain syndrome gene USP7 restricts neurotropic orthoflavivirus entry through cell intrinsic control of endosomal dynamics
Boris Bonaventure, Kyna Reyes, … Jeffrey R. Johnson·bioRxiv·Sep 10, 2026